Re: Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptors-positive primary breast cancer (multiple letter)

Journal of the National Cancer Institute

Volumn 95, Issue 18, 2003, Pages 1417-1418

  Spyratos, Frédérique ^a   Bouchet, Cécile ^a   Ferrero Poüs, Magali ^a   Tubiana Hulin, Michèle ^a   Hacène, Kamel ^a   Konecny, Gottfried ^b   Pegram, Mark ^b   Slamon, Dennis J ^b  

^a Ctr R H de Lutte Contre le Cancer   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TAMOXIFEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANALYSIS OF VARIANCE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG RECEPTOR BINDING; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; LETTER; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; BREAST TUMOR; CHEMISTRY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; NOTE; SURVIVAL; UPREGULATION;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 0141729461     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg068     Document Type: Letter

References (0)